Organon & Co. is a Jersey City-based global pharmaceutical company dedicated to advancing women's health through a robust portfolio that includes products in reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. With a strong focus on addressing unmet health needs, Organon leverages its deep industry expertise to deliver innovative solutions to global markets. Positioned at the forefront of the increasing demand for women's health interventions, Organon presents a compelling investment opportunity for institutional investors looking to enhance their exposure within the healthcare sector.
Click "Analyze" to generate stock analysis
OGN Price Trend and Signals
OGN Option Volumes & Open Interests (aggregated)
OGN Put Call Ratios and IV (aggregated)
OGN Financials
2025-10-29Somewhat Bearishprice_signal
Yearly low detected.
2025-10-28Somewhat Bearishprice_signal
Yearly low detected.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.